Freycon Fernand, Trombert-Paviot Béatrice, Casagranda Léonie, Frappaz Didier, Mialou Valérie, Armari-Alla Corinne, Gomez Frederic, Faure-Conter Cécile, Plantaz Dominique, Berger Claire
Childhood Cancer Registry of the Rhône-Alpes Region , Saint-Etienne , France.
Pediatr Hematol Oncol. 2014 Apr;31(3):225-36. doi: 10.3109/08880018.2013.829541. Epub 2013 Oct 2.
We studied academic and employment outcomes in 59 subjects who underwent allogeneic hematopoietic stem cell transplantation (a-HSCT) with fractionated total body irradiation (fTBI) for childhood leukemia, comparing them with, first, the general French population and, second, findings in 19 who underwent a-HSCT with chemotherapy conditioning. We observed an average academic delay of 0.98 years among the 59 subjects by Year 10 of secondary school (French class Troisième), which was higher than the 0.34-year delay in the normal population (P < .001) but not significantly higher than the delay of 0.68 years in our cohort of 19 subjects who underwent a-HSCT with chemotherapy. The delay was dependent on age at leukemia diagnosis, but not at fTBI. This delay increased to 1.32 years by the final year of secondary school (Year 13, Terminale) for our 59 subjects versus 0.51 years in the normal population (P = .0002), but did not differ significantly from the 1.08-year delay observed in our cohort of 19 subjects. The number of students who received their secondary school diploma (Baccalaureate) was similar to the expected rate in the general French population for girls (observed/expected = 1.02) but significantly decreased for boys (O/E = 0.48; CI: 95%[0.3-0.7]). Compared with 13.8% of the general population, 15.3% of the cancer survivors received no diploma (P = NS). Reported job distribution did not differ significantly between our cohort of childhood cancer survivors and the general population except that more female survivors were employed in intermediate-level professional positions. Academic difficulties after fTBI are common and their early identification will facilitate educational and professional achievement.
我们研究了59名接受分次全身照射(fTBI)进行异基因造血干细胞移植(a-HSCT)治疗儿童白血病的受试者的学业和就业情况,并将他们首先与法国普通人群进行比较,其次与19名接受化疗预处理的a-HSCT受试者的研究结果进行比较。我们观察到,到中学10年级(法国初中三年级)时,这59名受试者的平均学业延迟为0.98年,高于正常人群的0.34年延迟(P <.001),但并不显著高于我们那19名接受化疗的a-HSCT受试者队列中的0.68年延迟。这种延迟取决于白血病诊断时的年龄,而不是fTBI时的年龄。到中学最后一年(13年级,高中结业班)时,我们这59名受试者的延迟增加到1.32年,而正常人群为0.51年(P =.0002),但与我们那19名受试者队列中观察到的1.08年延迟没有显著差异。获得中学文凭(高中毕业证书)的学生人数,女孩与法国普通人群的预期率相似(观察值/预期值 = 1.02),但男孩则显著下降(O/E = 0.48;置信区间:95%[0.3 - 0.7])。与普通人群的13.8%相比, 15.3%的癌症幸存者没有获得文凭(P = 无显著性差异)。除了更多女性幸存者受雇于中级专业职位外,我们的儿童癌症幸存者队列与普通人群之间报告的就业分布没有显著差异。fTBI后的学业困难很常见,早期识别将有助于教育和职业成就。